Stimulatory cell lines for ex vivo expansion and activation of natural killer cells

T Kamiya, D Campana - US Patent 11,896,616, 2024 - Google Patents
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-
amino-3-phenylpropanoyl] amino]-3-phenylpropanoyl] amino]-4-methylpentanoyl] amino] …

Improving efficacy of cancer immunotherapy by genetic modification of natural killer cells

RA Burga, T Nguyen, J Zulovich, S Madonna… - Cytotherapy, 2016 - Elsevier
Natural killer (NK) cells are members of the innate immune system that recognize target cells
via activating and inhibitory signals received through cell receptors. Derived from the …

[HTML][HTML] Human iPSC-derived natural killer cells engineered with chimeric antigen receptors enhance anti-tumor activity

Y Li, DL Hermanson, BS Moriarity, DS Kaufman - Cell stem cell, 2018 - cell.com
Chimeric antigen receptors (CARs) significantly enhance the anti-tumor activity of immune
effector cells. Although most studies have evaluated CAR expression in T cells, here we …

Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy

H Zhu, DS Kaufman - Blood Science, 2019 - journals.lww.com
Adoptive immunotherapy using immune effector cells has revolutionized cancer treatments
with approval of two autologous chimeric antigen receptor (CAR) T cell therapies by the US …

[PDF][PDF] Genetically engineered pluripotent cell-derived natural killer cell therapy provides enhanced antibody dependent cellular cytotoxicity against hematologic …

H Zhu, R Bjordahl, S Gaidarova, P Rogers, R Blum… - Blood, 2017 - researchgate.net
RESULTS Figure 7. FT516 effectively mediates ADCC in an in vivo ovarian cancer model.
NSG mice were inoculated IP with 1E5 SKOV-3 cells expressing the firefly luciferase gene …

Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies

K Shankar, CM Capitini, K Saha - Stem cell research & therapy, 2020 - Springer
Natural killer (NK) cells play a crucial role in host immunity by detecting cells that
downregulate MHC class I presentation and upregulate stress ligands, as commonly seen in …

[HTML][HTML] Natural Killer Cells for Cancer Immunotherapy: Opportunities and Challenges

L Zhang, X Feng, Z Han, Z Han - Natural Killer Cells-Lessons and …, 2022 - intechopen.com
Natural killer (NK) cells are advantaged immune cells and play a pivotal role in both innate
and adaptive immune responses. To date, autogenous and allogenic NK cells have been …

Engineered and banked iPSCs for advanced NK-and T-cell immunotherapies

F Cichocki, SJC van der Stegen, JS Miller - Blood, 2023 - ashpublications.org
The development of methods to derive induced pluripotent stem cells (iPSCs) has propelled
stem cell research, and has the potential to revolutionize many areas of medicine, including …

An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells

NAP Lieberman, K DeGolier, K Haberthur… - Frontiers in …, 2018 - frontiersin.org
Recent advances in cellular therapies for patients with cancer, including checkpoint
blockade and ex vivo-expanded, tumor-specific T cells, have demonstrated that targeting the …

Redirected primary human chimeric antigen receptor natural killer cells as an “off-the-shelf immunotherapy” for improvement in cancer treatment

O Oberschmidt, S Kloess, U Koehl - Frontiers in Immunology, 2017 - frontiersin.org
Primary human natural killer (NK) cells recognize and subsequently eliminate virus infected
cells, tumor cells, or other aberrant cells. However, cancer cells are able to develop tumor …